Last reviewed · How we verify
SanaCutan Basiscreme — Competitive Intelligence Brief
phase 3
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
SanaCutan Basiscreme (SanaCutan Basiscreme) — Infectopharm Arzneimittel GmbH. SanaCutan Basiscreme is a topical emollient and skin barrier repair cream that hydrates and protects damaged or irritated skin.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| SanaCutan Basiscreme TARGET | SanaCutan Basiscreme | Infectopharm Arzneimittel GmbH | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- SanaCutan Basiscreme CI watch — RSS
- SanaCutan Basiscreme CI watch — Atom
- SanaCutan Basiscreme CI watch — JSON
- SanaCutan Basiscreme alone — RSS
Cite this brief
Drug Landscape (2026). SanaCutan Basiscreme — Competitive Intelligence Brief. https://druglandscape.com/ci/sanacutan-basiscreme. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing